Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Armand B. Turk
New York +1 212 841 1210 aturk@cov.com Download V-card

Armand Turk is a member of the firm’s Corporate Practice Group and focuses on life sciences transactions, including strategic collaborations, licensing, acquisitions and divestitures, and research and clinical agreements.

  • A multinational private equity firm in connection with a secondary reorganization transaction involving the sale of limited partnership interests to capital investment group and the transfer of portfolio companies to a newly-formed private equity fund.
  • A multinational Indian company in connection with its acquisition of a leading global music company.
  • A global biopharmaceutical in its acquisition of a clinical stage medical device company.
  • A leading biopharmaceutical company in an immuno-oncology research and development collaboration with a novel technology company.
  • A multinational biopharmaceutical company in an infectious disease collaboration and license transaction with a gene editing company.

Pro Bono

  • Report on ceasefire agreements for groups involved in conflict in Africa.

Previous Experience

  • Associate Director in the contracts group at a leading biotechnology company.